.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Deloitte
Fuji
Argus Health
Chubb
Teva
McKinsey
AstraZeneca
Baxter
McKesson

Generated: September 26, 2017

DrugPatentWatch Database Preview

Bracco Company Profile

« Back to Dashboard

What is the competitive landscape for BRACCO, and when can generic versions of BRACCO drugs launch?

BRACCO has forty-three approved drugs.

There are three US patents protecting BRACCO drugs.

There are one hundred and fifty-six patent family members on BRACCO drugs in twenty-eight countries.

Summary for Applicant: Bracco

Patents:3
Tradenames:65
Ingredients:37
NDAs:43
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco
CHOLOGRAFIN MEGLUMINE
iodipamide meglumine
INJECTABLE;INJECTION009321-007Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bracco
RENOVIST
diatrizoate meglumine; diatrizoate sodium
INJECTABLE;INJECTION010040-020Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bracco
PROHANCE MULTIPACK
gadoteridol
INJECTABLE;INJECTION021489-001Oct 9, 2003RXYesYes► Subscribe► Subscribe► Subscribe
Bracco
LUMASON
sulfur hexafluoride lipid-type a microspheres
FOR SUSPENSION;INTRAVENOUS203684-001Oct 15, 2014RXYesYes► Subscribe► Subscribe► Subscribe
Bracco
CYSTOGRAFIN DILUTE
diatrizoate meglumine
SOLUTION;URETHRAL010040-022Nov 9, 1982RXYesNo► Subscribe► Subscribe► Subscribe
Bracco
RENOTEC
technetium tc-99m ferpentetate kit
INJECTABLE;INJECTION017045-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bracco
READI-CAT 2 SMOOTHIES
barium sulfate
SUSPENSION;ORAL208143-002Jan 15, 2016RXYesNo► Subscribe► Subscribe► Subscribe
Bracco
ISOVUE-370
iopamidol
INJECTABLE;INJECTION020327-004Oct 12, 1994RXYesYes► Subscribe► Subscribe► Subscribe
Bracco
RENOVIST II
diatrizoate meglumine; diatrizoate sodium
INJECTABLE;INJECTION010040-019Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bracco
ROBENGATOPE
rose bengal sodium i-131
INJECTABLE;INJECTION016224-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Bracco

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bracco
MULTIHANCE MULTIPACK
gadobenate dimeglumine
INJECTABLE;INTRAVENOUS021358-001Nov 23, 2004► Subscribe► Subscribe
Bracco
ISOVUE-370
iopamidol
INJECTABLE;INJECTION018735-003Dec 31, 1985► Subscribe► Subscribe
Bracco
CARDIOGEN-82
rubidium chloride rb-82
INJECTABLE;INJECTION019414-001Dec 29, 1989► Subscribe► Subscribe
Bracco
PROHANCE MULTIPACK
gadoteridol
INJECTABLE;INJECTION021489-001Oct 9, 2003► Subscribe► Subscribe
Bracco
CHOLOVUE
iodoxamate meglumine
INJECTABLE;INJECTION018076-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Bracco
PROHANCE MULTIPACK
gadoteridol
INJECTABLE;INJECTION021489-001Oct 9, 2003► Subscribe► Subscribe
Bracco
PROHANCE
gadoteridol
INJECTABLE;INJECTION020131-001Nov 16, 1992► Subscribe► Subscribe
Bracco
PROHANCE
gadoteridol
INJECTABLE;INJECTION020131-001Nov 16, 1992► Subscribe► Subscribe
Bracco
CARDIOTEC
technetium tc-99m teboroxime kit
INJECTABLE;INJECTION019928-001Dec 19, 1990► Subscribe► Subscribe
Bracco
CHOLOVUE
iodoxamate meglumine
INJECTABLE;INJECTION018077-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Bracco

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,989,141Ultrasound contrast agents and methods of making and using them► Subscribe
6,136,293 Stable microbubbles suspensions containing saturated lamellar phospholipids► Subscribe
5,846,518 Gas mixtures useful as ultrasound contrast media contrast agents containing the media and method► Subscribe
5,271,928 Stable microbubbles suspensions injectable into living organisms► Subscribe
6,585,955 Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof► Subscribe
6,187,288 Stable microbubble suspensions as enhancement agents for ultrasonic echography► Subscribe
6,613,306 Ultrasound contrast agents and methods of making and using them► Subscribe
5,578,292 Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof► Subscribe
5,597,549 Stable microbubble suspensions as enhancement agents for ultrasound echography► Subscribe
5,567,414 Stable microbubbles suspensions injectable into living organisms► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Bracco Drugs

Country Document Number Estimated Expiration
Australia1033095► Subscribe
Norway314019► Subscribe
Finland116365► Subscribe
Germany10199055► Subscribe
Finland119973► Subscribe
Greece3022461► Subscribe
Japan2003505433► Subscribe
Hungary9502390► Subscribe
Mexico9300345► Subscribe
Russian Federation2110991► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Bracco Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB97/078United Kingdom► SubscribePRODUCT NAME: MANGAFODIPIR AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, IN PARTICULAR MANGAFODIPIR TRISODIUM; REGISTERED: UK EU/1/97/040/001 19970522; UK EU/1/97/040/002 19970522
C0055France► SubscribePRODUCT NAME: SULFATE DE SODIUM ANHYDRE, SULFATE DE MAGNESIUM HEPTAHYDRATE, SULFATE DE POTASSIUM; NAT. REGISTRATION NO/DATE: NL41696 20130426; FIRST REGISTRATION: 434323 20130220
C/GB07/011United Kingdom► SubscribePRODUCT NAME: GADOFOSVESET TRISODIUM; REGISTERED: UK EU/1/05/313/001 20051003; UK EU/1/05/313/002 20051003; UK EU/1/05/313/003 20051003; UK EU/1/05/313/004 20051003; UK EU/1/05/313/005 20051003; UK EU/1/05/313/006 20051003; UK EU/1/05/313/007 20051003; UK EU/1/05/313/008 20051003; UK EU/1/05/313/009 20051003
00061Netherlands► SubscribePRODUCT NAME: ZWAVELHEXAFLUORIDE; REGISTRATION NO/DATE: EU/1/01/177/001-002 20010326
C/GB00/021United Kingdom► SubscribePRODUCT NAME: (1-HYDROXY-2-(3-PYRIDINYL)ETHYLIDENE)BIS(PHOSPHONIC ACID) "RESIDRONATE" AND SALTS THEREOF, ESPECIALLY THE SODIUM SALT; REGISTERED: SE 15296 19991007; SE 15297 19991007; UK PL 00364/0070 20000316
0736Netherlands► SubscribePRODUCT NAME: TILMANOCEPT, DESGEWENST GELABELD MET TECHNETIUM TC 99M; REGISTRATION NO/DATE: EU/1/14/955 20141119
C/GB98/030United Kingdom► SubscribePRODUCT NAME: FOSPHENYTOIN SODIUM (3-HYDROXYMETHYL)-5,5-DIPHENYLHYDANTOIN DISODIUM PHOSPHATE ESTER); REGISTERED: UK 0019/0157 19980204
C0022France► SubscribePRODUCT NAME: MONTELUKAST SODIUM; REGISTRATION NO/DATE IN FRANCE: NL 23 133 DU 19980320; REGISTRATION NO/DATE AT EEC: 13 651 DU 19970825
C0021France► SubscribePRODUCT NAME: PEGAPTANIB SODIUM; REGISTRATION NO/DATE: EU/1/05/325/001 20060131
C0052France► SubscribePRODUCT NAME: SUGAMMADEX SODIUM; REGISTRATION NO/DATE: EU/1/08/466/001-002 20080725
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Argus Health
Farmers Insurance
Cerilliant
Express Scripts
Chubb
US Department of Justice
QuintilesIMS
Citi
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot